Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

29.4K
Overview
29.4K
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

1.2K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.2K
Hypersensitivities01:30

Hypersensitivities

2.8K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

972
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
972
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

2.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.5K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.1K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anaphylaxis and Epinephrine Use in Pregnancy.

The journal of allergy and clinical immunology. In practice·2026
Same author

World Allergy Organization survey on the diagnosis and management trends of perioperative anaphylaxis.

The World Allergy Organization journal·2026
Same author

Update on desensitization to chemotherapeutics and biologicals.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments.

Allergy·2026
Same author

Overview of allergic disease: Anaphylaxis - WAO White Book on Allergy 2026 - 2.11.

The World Allergy Organization journal·2026
Same author

An mRNA-delivered consensus allergen induces a neutralizing IgG response against food and pollen allergens.

Nature communications·2026
Same journal

Biosimilars in allergology: an outline in pediatric patients.

Current opinion in allergy and clinical immunology·2026
Same journal

The immunogenetic landscape of systemic lupus erythematosus.

Current opinion in allergy and clinical immunology·2026
Same journal

Circadian control of innate immunity: molecular mechanisms and implications for allergic disorders.

Current opinion in allergy and clinical immunology·2026
Same journal

Probiotics in allergic disease: from adjunct supplement to immune-modifying strategy (2026 update).

Current opinion in allergy and clinical immunology·2026
Same journal

Updates on drug-induced anaphylaxis in children.

Current opinion in allergy and clinical immunology·2026
Same journal

Beta-lactam de-labelling as a core antimicrobial stewardship strategy in the era of the antimicrobial resistance pandemic: a narrative review.

Current opinion in allergy and clinical immunology·2026
See all related articles

Related Experiment Video

Updated: Oct 28, 2025

Measuring Local Anaphylaxis in Mice
07:49

Measuring Local Anaphylaxis in Mice

Published on: October 14, 2014

19.6K

Anaphylaxis viewed by experts: unmet needs.

Anna Sala-Cunill1,2,3, Victoria Cardona1,2,3

  • 1Allergy Section, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Barcelona.

Current Opinion in Allergy and Clinical Immunology
|July 16, 2021
PubMed
Summary
This summary is machine-generated.

Anaphylaxis management requires improvement, with unmet needs identified in diagnosis, treatment, and prevention. Strategies involving education, policy, and digital health can enhance care for this life-threatening allergic reaction.

More Related Videos

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.7K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.6K

Related Experiment Videos

Last Updated: Oct 28, 2025

Measuring Local Anaphylaxis in Mice
07:49

Measuring Local Anaphylaxis in Mice

Published on: October 14, 2014

19.6K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.7K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.6K

Area of Science:

  • Allergy and Immunology
  • Emergency Medicine
  • Public Health

Background:

  • Anaphylaxis is a severe allergic reaction with suboptimal identification and management.
  • Current approaches to acute and long-term care present significant challenges.
  • There is a critical need for improved strategies to address anaphylaxis effectively.

Purpose of the Study:

  • To identify unmet needs in the comprehensive management of anaphylaxis.
  • To cover key aspects including epidemiology, diagnosis, treatment, and prevention.
  • To propose actionable strategies for improving anaphylaxis care.

Main Methods:

  • Systematic review of current literature on anaphylaxis management.
  • Analysis of epidemiological data, diagnostic criteria, and treatment protocols.
  • Identification of gaps in knowledge and clinical practice.

Main Results:

  • Unmet needs identified in epidemiology, severity scoring, and diagnostic criteria.
  • Challenges exist in managing anaphylaxis in infants and toddlers, understanding cofactors, and utilizing biomarkers.
  • Undertreatment and limited availability of epinephrine autoinjectors are significant concerns.

Conclusions:

  • Redefining diagnostic criteria and improving coding systems are crucial for better identification and research.
  • Digital health tools offer potential for improved anaphylaxis management.
  • Implementing targeted strategies in education, legislation, digital health, and research is essential to address identified unmet needs.